EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access

Deciphering the nuclear bile acid receptor FXR paradigm

Salvatore Modica, Raffaella M Gadaleta, Antonio Moschetta

Nuclear Receptor Signaling · 2010-01 · 8 (1)

DOI: 10.1621/nrs.08005 ↗

At a glance

Übersichtsarbeit in Nuclear Receptor Signaling, published online on 2010-11-19. Written by Salvatore Modica and 2 co-authors. Institution: Laboratory of Lipid Metabolism and Cancer, Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti, Italy. Cited 277 times so far (Crossref); 208 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Originally called retinoid X receptor interacting protein 14 (RIP14), the farnesoid X receptor (FXR) was renamed after the ability of its rat form to bind supra-physiological concentrations of farnesol. In 1999 FXR was de-orphanized since primary bile acids were identified as natural ligands. Strongly expressed in the liver and intestine, FXR has been shown to be the master transcriptional regulator of several entero-hepatic metabolic pathways with relevance to the pathophysiology of conditions such as cholestasis, fatty liver disease, cholesterol gallstone disease, intestinal inflammation and tumors. Furthermore, given the importance of FXR in the gut-liver axis feedbacks regulating lipid and glucose homeostasis, FXR modulation appears to have great input in diseases such as metabolic syndrome and diabetes. Exciting results from several cellular and animal models have provided the impetus to develop synthetic FXR ligands as novel pharmacological agents. Fourteen years from its discovery, FXR has gone from bench to bedside; a novel nuclear receptor ligand is going into clinical use.

Subjects

MeSH terms (MEDLINE)

AnimalsAtherosclerosisBile Acids and SaltsCholestasisDiabetes MellitusGallstonesGastrointestinal Stromal TumorsGene Expression RegulationGlucoseHyperlipidemiasIntestinal DiseasesLiver NeoplasmsLiver RegenerationRatsReceptors, Cytoplasmic and NuclearTranscription FactorsTriglyceridesReceptor, Farnesoid X-Activated

Substances

Bile Acids and SaltsGlucoseReceptors, Cytoplasmic and NuclearTranscription FactorsTriglyceridesReceptor, Farnesoid X-Activated

Authors and institutions

  • Laboratory of Lipid Metabolism and Cancer, Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti, Italy.

Cite

APA

Modica, S., Gadaleta, R. M., & Moschetta, A. (2010). Deciphering the nuclear bile acid receptor FXR paradigm. Nuclear Receptor Signaling, 8(1). https://doi.org/10.1621/nrs.08005

Vancouver

Modica S, Gadaleta RM, Moschetta A. Deciphering the nuclear bile acid receptor FXR paradigm. Nuclear Receptor Signaling. 2010;8(1). doi:10.1621/nrs.08005

BibTeX
@article{Modica2010,
  author = {Modica, Salvatore and Gadaleta, Raffaella M and Moschetta, Antonio},
  title = {Deciphering the nuclear bile acid receptor FXR paradigm},
  journal = {Nuclear Receptor Signaling},
  year = {2010},
  volume = {8},
  number = {1},
  doi = {10.1621/nrs.08005}
}
Start for free →